Transition summary · 2 pages
NF Transition Summary
Organize current NF care, monitoring, treatment history, medications, results, care-team contacts, open plans, and the records needed for the first adult visit.
Download transition summarySelf-Advocacy
Self-advocacy can mean asking for a clearer answer, requesting needed care, documenting a concern, or challenging an access barrier. You do not have to know every rule or handle every step alone.
Trusted starting points
Open an external care directory below, or use the combined directory on this page to search clinics and programs by name, location, and category.
Search Children’s Tumor Foundation-recognized clinics in the United States and Canada by location, NF type, age range, and areas of care.
Children’s Tumor Foundation Additional directoryReview another searchable list of NF clinics and doctors, including specialties, age ranges, locations, and contact information.
Neurofibromatosis Network Rare-disease helpFind rare-disease information, financial-assistance resources, communication tools, and help locating support.
NIH Genetic and Rare Diseases Information CenterNF care directory
Search CTF NF Clinic Network members and additional programs whose own listings identify NF or Neurofibromatosis care.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both — Pediatric and adult through age 25
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
Hospital-based NF care
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Linked page: General or directory page - confirm NF services with the program
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Program information available
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Pediatric
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Program information available
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Pediatric — Pediatric through age 21
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Pediatric
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Program information available
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis
Care areas: Multidisciplinary care
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Program information available
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Multidisciplinary care
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
NF-related specialty care
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis
Care areas: Multidisciplinary care
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Linked page: General or directory page - confirm NF services with the program
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Multidisciplinary care
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Program information available
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
Multidisciplinary NF clinic
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Multidisciplinary care
Reviewed information source: Memorial Sloan Kettering, Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
Hospital-based NF care
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Program information available
Linked page: General or directory page - confirm NF services with the program
Confirm current details with the program, including referrals, contact information, and availability.
NF research and clinical trials
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Program information available
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
NF-related specialty care
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Linked page: General or directory page - confirm NF services with the program
Confirm current details with the program, including referrals, contact information, and availability.
Pediatric NF care
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
Pediatric NF care
Age group: Pediatric
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
Adult NF care
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Pediatric — Pediatric through age 23
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Pediatric
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Adult
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Multispecialty care
Reviewed information source: Roswell Park Comprehensive Cancer Center
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Pediatric — Pediatric through age 21
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both — Pediatric and adult through age 21
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
Pediatric NF-related orthopedic care
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Linked page: NF services vary by Shriners location - confirm availability with the individual hospital
Confirm current details with the program, including referrals, contact information, and availability.
Pediatric NF clinic
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
Adult NF clinic
Age group: Adult
NF conditions: Not specified in reviewed source.
Care areas: Multidisciplinary care
Reviewed information source: Children’s Tumor Foundation and UAMS announcement
Reviewed: September 5, 2026
NF research or clinical trials: Program information available
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
NF2-related schwannomatosis care
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Program information available
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Multidisciplinary care
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Not specified in reviewed source.
NF conditions: Not specified in reviewed source.
Care areas: Not specified in reviewed source.
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both — Pediatric and adult through age 22
NF conditions: NF1, NF2-related schwannomatosis
Care areas: Not specified in reviewed source.
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Multidisciplinary care
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
CTF NF Clinic Network
Age group: Both
NF conditions: NF1, NF2-related schwannomatosis, Other schwannomatoses
Care areas: Multidisciplinary care
Reviewed information source: Neurofibromatosis Network directory
Reviewed: September 5, 2026
NF research or clinical trials: Not identified in this directory
Confirm current details with the program, including referrals, contact information, and availability.
Directories are a starting point
Clinic services, providers, age limits, insurance participation, and appointment availability can change. Contact the clinic directly to confirm current details. If symptoms are urgent, use appropriate emergency or local medical services rather than waiting for a specialty appointment.
This directory combines CTF NF Clinic Network members with additional programs whose own listings identify NF or Neurofibromatosis care. Labels clarify why each program is included. Clinic information can change. Confirm diagnoses served, age limits, referrals, insurance, telehealth, and appointment availability directly with the clinic.
Clinic comparison
Select programs from the directory above. The comparison uses information available in this directory and identifies details to confirm directly.
This comparison does not rank or recommend clinics. Details can change; confirm current information directly with each program.
Questions to confirm with each programPractical care support
Choose the kind of support and your state. National programs are shown alongside state or local starting points when a dependable directory is available.
Important: This finder currently emphasizes United States programs and state-specific starting points. People outside the U.S. should confirm comparable support through local health systems, government agencies, and NF organizations. Eligibility, service areas, medical-clearance requirements, notice requirements, cost, and availability vary. Confirm details directly before making travel plans.
Coordinated care
The right team depends on the person and the concerns being evaluated. An NF clinic may coordinate care across specialties rather than provide every service in one visit.
Pediatric to adult care
Health care transition is a gradual process of planning, transferring care, and becoming established in adult-centered care. The timing and team will differ from person to person, so begin early enough to reduce the chance of a gap in care.
Transition summary · 2 pages
Organize current NF care, monitoring, treatment history, medications, results, care-team contacts, open plans, and the records needed for the first adult visit.
Download transition summaryTransition checklist · 2 pages
Track the handoff, records, prescriptions, referrals, authorizations, appointments, care coordination, and remaining responsibilities.
Download transition checklistPractical preparation
Organize your health history, describe new concerns, plan your questions, and keep track of what happens next. The fillable forms can be completed digitally or printed.
U.S.-focused starting point
Disability protections may apply when NF or a related symptom substantially limits one or more major life activities. Protections and processes vary by setting and individual circumstances, so use these resources to prepare questions and confirm what applies to you.
Practical next steps
Use these steps to describe a concern, leave with a clear plan, follow up, respond to a denial, and keep a simple record of what happens next.
Practice applying the Hub
Choose a realistic situation, consider the available responses, and reveal what each approach may clarify—or leave unresolved. These scenarios teach communication and decision-preparation skills; they do not diagnose, predict outcomes, or replace professional advice.
You have several concerns for a short visit and are unsure how to make sure the most important issues are addressed.
Prefer a ready-made starting point?
Select a maintained starting prompt, review it, and copy it into the writing assistant you prefer.
Add your situation, notes, or existing draft to create your prompt. The other fields are optional.
Ready-made prompt library
The second list changes with your first selection. Prompt purposes such as understanding, preparing, comparing, or communicating are built into the focused topics.
Copy the finished prompt, then open the assistant you prefer.
Where should I start?
Choose the kind of issue and your state. This finder points to authoritative starting places; it does not decide which law applies, determine eligibility, or calculate a deadline.
Important: Request processes and legal deadlines can vary. Document communications and contact the appropriate agency or support organization promptly.
The Americans with Disabilities Act may protect qualified workers and applicants from disability discrimination and may require reasonable accommodations. Some state laws cover additional employers or situations.
Section 504 prohibits disability discrimination by schools receiving federal funding. Eligible public-school students may receive accommodations through a 504 plan or specialized services through an Individualized Education Program under IDEA.
Many health plans must provide a process to appeal a denial. Depending on the plan and issue, an independent external review may also be available. Deadlines and procedures are plan-specific.
Layered plain-language reference
Search terms you may encounter in NF care, research, insurance, workplace, education, and advocacy settings. Open any row for the complete definition, helpful context, related terms, and a relevant Hub starting point.
An umbrella term often used for NF1, NF2-related schwannomatosis, and other forms of schwannomatosis.
An umbrella term often used for NF1, NF2-related schwannomatosis, and other forms of schwannomatosis. These are distinct conditions with different features and care needs.
Ask which specific NF condition is being discussed; information for one type may not apply to another.
“What does this term mean in my situation, and what action—if any—should I take next?”
A genetic condition associated with features that can include café-au-lait macules, freckling, neurofibromas, learning differences, bone changes, and certain tumors.
A genetic condition associated with features that can include café-au-lait macules, freckling, neurofibromas, learning differences, bone changes, and certain tumors. Features vary widely.
A diagnosis does not predict one fixed course. Individual symptoms, history, and monitoring needs matter.
“What does this term mean in my situation, and what action—if any—should I take next?”
The current name for the condition previously called NF2.
The current name for the condition previously called NF2. It is associated especially with vestibular schwannomas and may also involve other tumors of the nervous system.
Older records and sources may still use “NF2.” The updated name helps distinguish it within the schwannomatosis group.
“What does this term mean in my situation, and what action—if any—should I take next?”
NF2-SWN is a common abbreviation for NF2-related schwannomatosis, the current name for the condition previously called NF2.
NF2-SWN is a common abbreviation for NF2-related schwannomatosis, the current name for the condition previously called NF2.
Older sources may say NF2, while newer sources may use NF2-SWN. Confirm that both sources are discussing the same condition and terminology.
“What does this term mean in my situation, and what action—if any—should I take next?”
A group of genetic conditions associated with schwannomas.
A group of genetic conditions associated with schwannomas. Symptoms, tumor locations, genetic causes, and care needs differ among people.
Ask whether a source means the overall group or a particular schwannomatosis type.
“What does this term mean in my situation, and what action—if any—should I take next?”
SWN is an abbreviation sometimes used for schwannomatosis, a group of conditions associated with schwannomas.
SWN is an abbreviation sometimes used for schwannomatosis, a group of conditions associated with schwannomas.
SWN may refer to the broader group or appear within a condition name such as NF2-SWN. Check which specific schwannomatosis type a source means.
“What does this term mean in my situation, and what action—if any—should I take next?”
A change in a gene that evidence indicates can cause or contribute to a genetic condition.
A change in a gene that evidence indicates can cause or contribute to a genetic condition. A laboratory report may use this term instead of mutation.
The exact variant, laboratory classification, inheritance, and clinical context can affect how a result is interpreted.
“What does this term mean in my situation, and what action—if any—should I take next?”
A genetic change for which available evidence is not sufficient to classify it as disease-causing or benign.
A genetic change for which available evidence is not sufficient to classify it as disease-causing or benign. A VUS generally should not be treated as a confirmed diagnosis by itself.
Classification may change as evidence develops. Ask how the result should and should not affect care or family testing.
“What does this term mean in my situation, and what action—if any—should I take next?”
A situation in which a genetic variant is present in some of a person's cells but not all of them.
A situation in which a genetic variant is present in some of a person's cells but not all of them. This can affect symptoms and whether a variant is detected in a blood test.
Testing approach and tissue sampled can matter when mosaicism is suspected.
“What does this term mean in my situation, and what action—if any—should I take next?”
A process that helps people understand genetic test options and results, inheritance, family implications, and possible next steps.
A process that helps people understand genetic test options and results, inheritance, family implications, and possible next steps.
Genetic counseling supports informed choices; it does not require someone to pursue testing.
“What does this term mean in my situation, and what action—if any—should I take next?”
A usually benign tumor that develops from cells associated with nerves.
A usually benign tumor that develops from cells associated with nerves. Neurofibromas can occur in different forms and locations.
The tumor type, location, symptoms, growth, and effect on function help guide discussion and follow-up.
“What does this term mean in my situation, and what action—if any—should I take next?”
A neurofibroma arising in or on the skin.
A neurofibroma arising in or on the skin. The number, size, and effect on comfort or daily life vary.
Impact can include discomfort, irritation, appearance concerns, and practical effects even when a tumor is benign.
“What does this term mean in my situation, and what action—if any—should I take next?”
cNF is a common research abbreviation for a cutaneous neurofibroma, a neurofibroma arising in or on the skin.
cNF is a common research abbreviation for a cutaneous neurofibroma, a neurofibroma arising in or on the skin.
The abbreviation may be pluralized as cNFs. Confirm that a source is discussing cutaneous rather than plexiform neurofibromas.
“What does this term mean in my situation, and what action—if any—should I take next?”
A neurofibroma that grows along multiple branches of a nerve and may involve nearby tissue.
A neurofibroma that grows along multiple branches of a nerve and may involve nearby tissue. It is associated with NF1 and may require monitoring or treatment.
Location, growth, pain, function, imaging, and other changes can affect the care discussion.
“What does this term mean in my situation, and what action—if any—should I take next?”
PN and pNF are abbreviations used for plexiform neurofibroma, a tumor that grows along multiple branches of a nerve.
PN and pNF are abbreviations used for plexiform neurofibroma, a tumor that grows along multiple branches of a nerve.
Abbreviations vary across sources. Confirm the full tumor type instead of assuming every use of PN refers to a plexiform neurofibroma.
“What does this term mean in my situation, and what action—if any—should I take next?”
A usually benign tumor arising from Schwann cells, which help insulate peripheral nerves.
A usually benign tumor arising from Schwann cells, which help insulate peripheral nerves. Symptoms depend in part on the nerve and location involved.
The same tumor type can affect people differently depending on its size, location, growth, and nearby structures.
“What does this term mean in my situation, and what action—if any—should I take next?”
A schwannoma involving a nerve responsible for hearing and balance.
A schwannoma involving a nerve responsible for hearing and balance. It may affect hearing, balance, or other nearby functions.
Hearing tests, imaging, symptoms, growth, and personal goals may all matter when reviewing options.
“What does this term mean in my situation, and what action—if any—should I take next?”
A tumor arising from the membranes surrounding the brain or spinal cord.
A tumor arising from the membranes surrounding the brain or spinal cord. Many are benign, but effects and treatment needs depend on size, location, growth, and symptoms.
“Benign” describes cancer behavior; it does not automatically mean a tumor has no health or functional impact.
“What does this term mean in my situation, and what action—if any—should I take next?”
A cancer arising from cells associated with peripheral nerves.
A cancer arising from cells associated with peripheral nerves. People should discuss concerning new or changing symptoms with an appropriate clinician; this glossary cannot determine urgency.
This term requires professional evaluation and should not be used to self-diagnose a symptom or imaging finding.
“What does this term mean in my situation, and what action—if any—should I take next?”
Care coordinated across more than one specialty, such as genetics, neurology, oncology, surgery, hearing, pain management, psychology, or rehabilitation.
Care coordinated across more than one specialty, such as genetics, neurology, oncology, surgery, hearing, pain management, psychology, or rehabilitation.
Ask who coordinates the overall plan and how information moves between specialties.
“What does this term mean in my situation, and what action—if any—should I take next?”
The original accessible PDF remains available for appointments, meetings, and offline reference.
Tips for Sharing Your Story
Personal stories can build understanding, reduce isolation, and show why better research, care, and support matter. You decide what to say, who may hear it, and what remains private.
Build visual instructions
Turn a fact, story excerpt, advocacy message, or response created with another prompt from this site into a complete set of instructions for GPT or another AI assistant.
Act as a visual communication designer supporting responsible NF education and advocacy. Create a social media card formatted as a square post for general public. Use this source material: [Paste or write the source material here.] Communication goal: [State what the graphic should help the audience understand, feel, or do.] Call to action: No call to action supplied; suggest one only if it follows naturally from the goal. Content that must be included: No additional required content supplied. Content to avoid or keep private: Do not add private or identifying information. Design direction: Warm, clear, and hopeful. Working approach: Create the draft from the supplied material. Identify important gaps without requiring the user to answer more questions. Requirements: - Preserve the meaning of the source material without inventing medical claims, statistics, quotations, personal details, or sources. - If a factual or medical claim is not supported by a source in the supplied text, flag it for verification instead of presenting it as established fact. - Keep the main message concise and readable. Suggest a short headline, supporting text, and a clear visual hierarchy. - Use respectful, non-stigmatizing language. Do not imply that one person’s experience represents everyone with NF. - Do not display private health information, names, provider details, exact locations, or other identifiers unless the user explicitly confirms they may be public. - If the source material came from another AI response, treat it as an unverified draft and identify any claims that need an original source. - Include a small source line when a reliable source is provided. Otherwise label the content as a personal advocacy message. - If the tool supports image generation, create the finished graphic after presenting the final copy. Otherwise provide a production-ready design brief that can be pasted into an image tool or recreated in Canva. - Respect the selected format, keep all text inside safe margins, and avoid placing essential text where a social platform may crop it. - Return: (1) final card copy, (2) layout instructions, (3) color and typography guidance, (4) accessibility alt text, and (5) a final verification checklist. Do not create or imply a medical endorsement.
Copy the finished prompt, then open the assistant you prefer.
Create a writing prompt
Choose the kind of help, audience, format, tone, and optional word count, then describe your purpose, what you want to include, and your boundaries.
Copy prompt is unavailable until you complete both required story fields above.
Add your goal and the experiences or message you want to include to create your prompt.
Copy the finished prompt, then open the assistant you prefer.